How does folic acid supplementation affect serum folate concentrations in pregnant Turkish women?

Abstract

Aim: To determine the effect of the use of folic acid supplementation on serum folate levels in Turkish pregnant women. Material and Method: Clinical records of a total of 397 patients were retrospectively examined. The patients were recruited into 2 groups based on folic acid supplementation. Group 1 included 294 women who did not take any folic acid tablets before or during pregnancy and Group 2 consisted of 103 women who regularly took 400 mcg of folic acid daily, starting from the preconception period. Both groups were compared with respect to demographic and biochemical characteristics. Results: The patients in Group 1 and 2 had statistically similar pre-pregnancy and pregnancy hemoglobin, pre-pregnancy and pregnancy serum calcium, and pre-pregnancy and pregnancy serum folate concentrations (p=0.544, p=0.549, p=0.289, p=0.299, p=0.072, and p=0.061 respectively). No statistically significant difference was determined between pre-pregnancy and pregnancy folate concentrations in Group 1 (p=0.059). Pre-pregnancy and pregnancy folate concentrations were statistically similar in Group 2 (p=0.057). Both study groups were determined as statistically similar with respect to perinatal outcomes, including molar pregnancy, intrauterine demise, neural tube defects, ventricular septal defect, fetal growth restriction, preeclampsia, preterm birth, birth weight, neonatal intensive care unit admission, and 1st minute and 5th minute Apgar scores (p=0.760, p=0.576, p=0.382, p=0.553, p=0.452, p=0.940, p=0.683, p=0.855, p=0.710, p=0.910, and p=0.924 respectively). Discussion: Based on the findings of the present study, it may be considered that serum folate concentrations in pregnant women can be maintained by dietary intake alone of over 4.5 ng/ml.